Doherty institute ( australia ) vaccine study currently being done on 500 NHS workers in the uk, already seen to work in chimps, looks to be commercially available by september to the UK. Downside like many of the vaccines being trailed is that they can't vaccinate over 60s or those with underlying issues, basically the current group that are dying. Those people will have to survive with treatment of which there are many that are currently showing more than promise, they just don't cure death,many of the virus victims are already terminal. The position being considered if the general population is vaccinated, this will stop the spread to the at risk group or at least not exhaust the health systems, basically the vaccine will only deliver what herd immunity would but in a far more controlled manner. Apparently.
But again where states are managing their hospitals and health systems from positions of potential liability and are not using unapproved treatments for fear of liability, this could go on. Absolute madness.
